US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

CERo Therapeutics Holdings, Inc. - Common Stock (NQ:CERO)

0.0951 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CERo Therapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
CERo Therapeutics Holdings, Inc. Presents Encouraging Preclinical Data Demonstrating CER-1236 May be Targeted to Ovarian Cancer Cells Without Toxicities at 2025 SITC Spring Scientific Cellular Therapy for Solid Tumors Meeting
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
CERo Therapeutics Holdings, Inc. Highlights Progress
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
CERo Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
Friday's after hours session: top gainers and losers ↗
After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Tumbles Over 200 Points; Alibaba Posts Upbeat Sales ↗
 
Via Benzinga
News headline image
CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
Why Domino's Pizza Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Crude Oil Down 3%; Aramark Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
CERo Therapeutics Stock Is Soaring Monday: What's Going On? ↗
CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound. 
Via Benzinga
News headline image
Nasdaq Moves Lower; Canaan Shares Surge ↗
 
Via Benzinga
News headline image
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
CERo Therapeutics, Inc. Provides Corporate Update
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
News headline image
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump ↗
 
Via Benzinga
Topics Stocks
News headline image
Crude Oil Down Over 1%; Stitch Fix Shares Plummet ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >